NovoCure Limited (NASDAQ:NVCR – Get Free Report) Director W Anthony Vernon sold 964 shares of the business’s stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $23.89, for a total transaction of $23,029.96. Following the sale, the director now owns 164,833 shares of the company’s stock, valued […]
NovoCure Limited (NASDAQ:NVCR – Get Free Report) Director W Anthony Vernon sold 964 shares of the business’s stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $23.89, for a total value of $23,029.96. Following the sale, the director now owns 164,833 shares of the company’s stock, valued […]
Item 5.07 Submission of Matters to a Vote of Security Holders.
On March 29, 2023, the Registrant held its Annual Meeting of Stockholders, at
which directors were elected, Ernst & Young LLP s. | March 31, 2023